Carl P. Sherr & Co’s Bristol-Myers Squibb BMY Stock Holding History

Carl P. Sherr & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$453K	Buy	7,468 +532	+8%	+$31K	0.21%	80
2025 Q4	$382K	Buy	+6,936	New	+$334K	0.17%	91
2023 Q4	–	Sell	-7,469	Closed	-$433K	–	116
2023 Q3	$433K	Hold	7,469	–	–	0.29%	75
2023 Q2	$478K	Hold	7,469	–	–	0.31%	73
2023 Q1	$518K	Hold	7,469	–	–	0.37%	65
2022 Q4	$537K	Buy	7,469 +130	+2%	+$9.8K	0.41%	62
2022 Q3	$522K	Hold	7,339	–	–	0.42%	61
2022 Q2	$565K	Buy	7,339 +300	+4%	+$22.8K	0.42%	62
2022 Q1	$514K	Sell	7,039 -300	-4%	-$20.1K	0.35%	75
2021 Q4	$458K	Buy	7,339 +75	+1%	+$4.4K	0.28%	82
2021 Q3	$430K	Hold	7,264	–	–	0.34%	63
2021 Q2	$485K	Hold	7,264	–	–	0.33%	71
2021 Q1	$459K	Sell	7,264 -1,007	-12%	-$62.7K	0.35%	72
2020 Q4	$513K	Sell	8,271 -50	-0.6%	-$3.07K	0.41%	71
2020 Q3	$502K	Hold	8,321	–	–	0.45%	68
2020 Q2	$489K	Hold	8,321	–	–	0.49%	67
2020 Q1	$464K	Hold	8,321	–	–	0.55%	62
2019 Q4	$534K	Buy	+8,321	New	+$477K	0.52%	64

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carl P. Sherr & Co's BMY Position: Q1 2026 in Review

Carl P. Sherr & Co increased its Bristol-Myers Squibb (BMY) stake by 7.7% in Q1 2026, buying an estimated $31K and bringing the position to 7,468 shares worth $453K. The position accounts for 0.21% of the portfolio, ranked #80.

Carl P. Sherr & Co first reported a position in BMY in Q4 2019 and has held it in 18 quarters since. The position peaked at $565K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Carl P. Sherr & Co held 7,468 shares of Bristol-Myers Squibb worth $453K as of Q1 2026.
Carl P. Sherr & Co bought 532 Bristol-Myers Squibb shares in Q1 2026, an estimated $31K.
Bristol-Myers Squibb made up 0.21% of Carl P. Sherr & Co's portfolio in Q1 2026, its #80 holding.
Carl P. Sherr & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 18 quarters since.
Carl P. Sherr & Co's Bristol-Myers Squibb position peaked at $565K in Q2 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Carl P. Sherr & Co's 13F filing for Q1 2026, filed 7 May 2026.